pUltra BCR-ABL F311L
(Plasmid
#235029)
-
PurposeLentiviral expression of BCR-ABL F311L
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 235029 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
-
Vector backbonepUltra
-
Vector typeLentiviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameBCR-ABL
-
SpeciesH. sapiens (human)
-
MutationF311L
-
Entrez GeneABL1 (a.k.a. ABL, BCR-ABL, CHDSKM, JTK7, bcr/abl, c-ABL, c-ABL1, p150, v-abl)
- Promoter human ubiquitin C
-
Tag
/ Fusion Protein
- EGFP-P2A (N terminal on insert)
Cloning Information
- Cloning method Other
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pUltra BCR-ABL F311L was a gift from Justin Pritchard (Addgene plasmid # 235029 ; http://n2t.net/addgene:235029 ; RRID:Addgene_235029) -
For your References section:
Dual functional genomics reveals a broad and convergent landscape of asciminib resistance in BCR::ABL1. Sokirniy I, Pritchard J. Genome Med. 2026